Transgenesis and web resources in quail

  1. Olivier Serralbo  Is a corresponding author
  2. David Salgado
  3. Nadège Véron
  4. Caitlin Cooper
  5. Marie-Julie Dejardin
  6. Timothy Doran
  7. Jérome Gros  Is a corresponding author
  8. Christophe Marcelle  Is a corresponding author
  1. Monash University, Australia
  2. Aix Marseille University, France
  3. CSIRO Health & Biosecurity, Australia
  4. University of Lyon 1 UCBL, France
  5. Pasteur Institute, CNRS UMR3738, France

Abstract

Due to its amenability to manipulations, to live observation and its striking similarities to mammals, the chicken embryo has been one of the major animal models in biomedical research. Although it is technically possible to genome-edit the chicken, its long generation time (6 months to sexual maturity) makes it an impractical lab model and has prevented it widespread use in research. The Japanese quail (Coturnix coturnix japonica) is an attractive alternative, very similar to the chicken, but with the decisive asset of a much shorter generation time (1.5 months). In recent years, transgenic quail lines have been described. Most of them were generated using replication-deficient lentiviruses, a technique that presents diverse limitations. Here, we introduce a novel technology to perform transgenesis in quail, based on the in vivo transfection of plasmids in circulating Primordial Germ Cells (PGCs). This technique is simple, efficient and allows using the infinite variety of genome engineering approaches developed in other models. Furthermore, we present a website centralizing quail genomic and technological information to facilitate the design of genome-editing strategies, showcase the past and future transgenic quail lines and foster collaborative work within the avian community.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Olivier Serralbo

    Australian Regenerative Medicine Institute, Monash University, Clayton, Australia
    For correspondence
    olivier.serralbo@monash.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0808-3464
  2. David Salgado

    INSERM, MMG, U1251, Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Nadège Véron

    Australian Regenerative Medicine Institute, Monash University, Clayton, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Caitlin Cooper

    Australian Animal Health Laboratory, CSIRO Health & Biosecurity, Geelong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Marie-Julie Dejardin

    NeuroMyoGene Institute, University of Lyon 1 UCBL, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Timothy Doran

    Australian Animal Health Laboratory, CSIRO Health & Biosecurity, Geelong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Jérome Gros

    Department of Developmental and Stem Cell Biology, Pasteur Institute, CNRS UMR3738, Paris, France
    For correspondence
    jgros@pasteur.fr
    Competing interests
    The authors declare that no competing interests exist.
  8. Christophe Marcelle

    Australian Regenerative Medicine Institute, Monash University, Clayton, Australia
    For correspondence
    christophe.marcelle@monash.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9612-7609

Funding

AFM-Téléthon (Research grant)

  • Christophe Marcelle

Stem Cells Australia (Research grant)

  • Olivier Serralbo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication

Ethics

Animal experimentation: All procedures were approved by a Monash University Animal Ethics Committee (ERM ID 15002, ERM ID 18809) in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes (8th Edition, 2013).

Copyright

© 2020, Serralbo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,911
    views
  • 382
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Olivier Serralbo
  2. David Salgado
  3. Nadège Véron
  4. Caitlin Cooper
  5. Marie-Julie Dejardin
  6. Timothy Doran
  7. Jérome Gros
  8. Christophe Marcelle
(2020)
Transgenesis and web resources in quail
eLife 9:e56312.
https://doi.org/10.7554/eLife.56312

Share this article

https://doi.org/10.7554/eLife.56312

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.

    1. Genetics and Genomics
    Yi Li, Long Gong ... Shangbang Gao
    Research Article

    Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.